These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1424055)

  • 1. The relation between atherosclerosis and thrombosis.
    Loscalzo J
    Circulation; 1992 Dec; 86(6 Suppl):III95-9. PubMed ID: 1424055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis.
    Smith EB
    Clin Haematol; 1986 May; 15(2):355-70. PubMed ID: 3524931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic risk factors for atherosclerosis.
    Dobroski DR; Loscalzo J
    Coron Artery Dis; 1996 Dec; 7(12):919-32. PubMed ID: 9116935
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lipoprotein-mediated functional changes in the fibrinolytic system in the genesis of atherosclerosis].
    García Frade LJ; García Avello A
    Sangre (Barc); 1991 Feb; 36(1):25-8. PubMed ID: 1649496
    [No Abstract]   [Full Text] [Related]  

  • 5. [Participation of platelets in the progression of atherosclerosis].
    Capron L; Bruneval P
    Rev Prat; 1989 Nov; 39(25):2207-14. PubMed ID: 2595215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
    Salobir B; Sabovic M; Zupan IP; Ponikvar JB
    Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lipids on thrombotic mechanisms in atherosclerosis.
    Tousoulis D; Davies G; Ambrose J; Tentolouris C; Stefanadis C; Toutouzas P
    Int J Cardiol; 2002 Dec; 86(2-3):239-47. PubMed ID: 12419562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots.
    Neuss S; Schneider RK; Tietze L; Knüchel R; Jahnen-Dechent W
    Cells Tissues Organs; 2010; 191(1):36-46. PubMed ID: 19390164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in atheroma: implications for plaque rupture and platelet-collagen interaction.
    Lassila R
    Eur Heart J; 1993 Dec; 14 Suppl K():94-7. PubMed ID: 8131797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Gordon Wilson lecture: function of blood platelets and their role in thrombosis.
    Mustard JF
    Trans Am Clin Climatol Assoc; 1976; 87():104-27. PubMed ID: 785767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood coagulation system and fibrinolysis in glomerulonephritis (review of the literature)].
    Panchenko VM; Gilunova NI; Kozhomkulova BZh
    Lab Delo; 1977; (8):451-4. PubMed ID: 72846
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic haemostasis after intermittent pneumatic compression. Clues for the investigation of DVT prophylaxis and travellers thrombosis.
    Giddings JC; Morris RJ; Ralis HM; Jennings GM; Davies DA; Woodcock JP
    Clin Lab Haematol; 2004 Aug; 26(4):269-73. PubMed ID: 15279664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of hemostatic factors in atherogenesis].
    Gensini GF; Prisco D; Falciani M; Giusti B
    Cardiologia; 1997 Oct; 42(10):1007-19. PubMed ID: 9534275
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemostasis and atherosclerosis.
    Warkentin TE
    Can J Cardiol; 1995 May; 11 Suppl C():29C-34C. PubMed ID: 7750046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of platelets in atherosclerosis and arterial thrombosis].
    Boneu B
    Rev Prat; 1989 Nov; 39(25):2215-8. PubMed ID: 2595216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen, fibrin turnover, endothelial products and vascular surgery.
    Woodburn KR; Lowe GD
    Br J Surg; 1997 Aug; 84(8):1059-64. PubMed ID: 9278641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAFI and pancreatic carboxypeptidase B modulate in vitro capillary tube formation by human microvascular endothelial cells.
    Guimarães AH; Laurens N; Weijers EM; Koolwijk P; van Hinsbergh VW; Rijken DC
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2157-62. PubMed ID: 17673703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.